Evidence map›Paper›PMID 30393518›Full record

ReviewChemical science2018

Asking more from metabolic oligosaccharide engineering.

Pierre-André Gilormini, Anna R Batt, Matthew R Pratt, Christophe Biot

Open access · diamondAbstract readReview
In one paragraph

Review in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Synthetic Lipid Biology.Chemical reviews · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Synthesis of Cell-PermeableThe Journal of organic chemistry · 2021
    Article
  16. Biosynthetic Glycan Labeling.Journal of the American Chemical Society · 2021
    Article
  17. Article
  18. Review
  19. Chemical reporters to study mammalian O-glycosylation.Biochemical Society transactions · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pierre-André GilorminiUniversity of Lille , CNRS UMR 8576 , UGSF - Unité de Glycobiologie Structurale et Fonctionnelle , F-59000 Lille , France . Email: christophe.biot@univ-lille.fr.ORCID 0000-0003-1491-1174
Anna R BattDepartment of Chemistry , University of Southern California , 840 Downey Way , LJS 250 Los Angeles , CA 90089 , USA.
Matthew R PrattDepartment of Chemistry , University of Southern California , 840 Downey Way , LJS 250 Los Angeles , CA 90089 , USA.ORCID 0000-0003-3205-5615
Christophe BiotUniversity of Lille , CNRS UMR 8576 , UGSF - Unité de Glycobiologie Structurale et Fonctionnelle , F-59000 Lille , France . Email: christophe.biot@univ-lille.fr.ORCID 0000-0002-7396-1959
Université de Lille · FRUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycans form one of the four classes of biomolecules, are found in every living system and present a huge structural and functional diversity. As an illustration of this diversity, it has been reported that more than 50% of the human proteome is glycosylated and that 2% of the human genome is dedicated to glycosylation processes. Glycans are involved in many biological processes such as signalization, cell-cell or host pathogen interactions, immunity,

Identifiers

PMID30393518
PMCPMC6187459
OpenAlexW2890295631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.